January 10, 2017
Otsuka Pharmaceutical said on January 6 that it has filed a new drug application in Japan for its novel antipsychotic drug brexpiprazole for the treatment of schizophrenia. Brexpiprazole is being developed jointly with Danish partner Lundbeck. It is a serotonin-dopamine...read more